MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹5.92 Cr | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹5.92 Cr |
| Mar2024 | ₹4.56 Cr |
| Mar2023 | ₹3.25 Cr |
| Mar2022 | ₹1.86 Cr |
| Mar2021 | ₹2.11 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.92 Cr | 29.85 | |
| Mar2024 | ₹4.56 Cr | 40.19 | |
| Mar2023 | ₹3.25 Cr | 75.22 | |
| Mar2022 | ₹1.86 Cr | -12.08 | |
| Mar2021 | ₹2.11 Cr | - | |
Compare Long Term Provisions of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,296.5 Cr | -5.3% | -9.5% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -5.3% |
-9.5% |
-36.1% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses